AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36071520 — intervention group
Group type: EXPERIMENTAL
Intervention: dihydroartemisinin‐piperaquine (DHA/PPQ)
Number of subjects: 211
Study 36071520 — intervention group
Group type: EXPERIMENTAL
Intervention: atovaquone‐proguanil (ATQ/PG)
Number of subjects: 211
Study 36265753 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 404
Study 36265753 — intervention group
Group type: EXPERIMENTAL
Intervention: Visit-to-visit variability (VV) of SBP
Number of subjects: 404
Study 35794044 — intervention group
Group type: EXPERIMENTAL
Intervention: Early oral feeding
Number of subjects: 110
Study 35794044 — intervention group
Group type: COMPARATOR
Intervention: Late oral feeding
Number of subjects: 110
Study 33382381 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based support and coaching (IBSC)
Number of subjects: 44
Study 33382381 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 44
Study 34583100 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐Behavioral Therapy for Seasonal Affective Disorder (CBT‐SAD)
Number of subjects: 177
Study 34583100 — intervention group
Group type: COMPARATOR
Intervention: Light Therapy (LT)
Number of subjects: 177
Study 34015829 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga therapy (Group 2)
Number of subjects: 97
Study 34015829 — intervention group
Group type: COMPARATOR
Intervention: Guideline-directed therapy (Group 1)
Number of subjects: 97
Study 35361630 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib plus chemotherapy (carboplatin and nab-paclitaxel)
Number of subjects: 243
Study 35361630 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (carboplatin and nab-paclitaxel)
Number of subjects: 243
Study 35361630 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib plus chemotherapy
Number of subjects: 243
Study 35361630 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 243
Study 33810776 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator training (8 sessions over 4 weeks)
Number of subjects: 22
Study 33810776 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 22
Study 32857933 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (15 mg/d forced titration to 20 mg/d)
Number of subjects: 51
Study 32857933 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 32857933 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 51
Study 35088565 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% saline rinses (SR)
Number of subjects: 37
Study 35088565 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal mouthwash (HMW)
Number of subjects: 37
Study 35088565 — intervention group
Group type: COMPARATOR
Intervention: 0.12% chlorhexidine (CHX)
Number of subjects: 37
Study 35088565 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (SR, HMW, CHX)
Number of subjects: 37
Study 34046502 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-bridging external fixation technique
Number of subjects: 28
Study 34046502 — intervention group
Group type: COMPARATOR
Intervention: Open reduction and internal fixation
Number of subjects: 28
Study 34046502 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 28
Study 32406655 — intervention group
Group type: EXPERIMENTAL
Intervention: deproteinized bovine bone + collagen plug
Number of subjects: 24
Study 32406655 — intervention group
Group type: EXPERIMENTAL
Intervention: deproteinized bovine bone + xenogeneic collagen matrix
Number of subjects: 24
Study 34254980 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behaviour therapy (n=150)
Number of subjects: 302
Study 34254980 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU, n=152)
Number of subjects: 302
Study 33384555 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational telephone intervention (IG)
Number of subjects: 1484
Study 33384555 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 1484
Study 34035091 — intervention group
Group type: EXPERIMENTAL
Intervention: Totally laparoscopic distal gastrectomy (TLDG)
Number of subjects: 722
Study 34035091 — intervention group
Group type: COMPARATOR
Intervention: Totally robotic distal gastrectomy (TRDG)
Number of subjects: 722
Study 34035091 — intervention group
Group type: EXPERIMENTAL
Intervention: TLDG
Number of subjects: 722
Study 34035091 — intervention group
Group type: COMPARATOR
Intervention: TRDG
Number of subjects: 722
Study 32943094 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate smart feedback via a mobile application
Number of subjects: 68
Study 32943094 — intervention group
Group type: COMPARATOR
Intervention: Monitoring adherence and inhalation technique without feedback
Number of subjects: 68
Study 34360118 — intervention group
Group type: EXPERIMENTAL
Intervention: FUNPALs Playgroup (n = 24)
Number of subjects: 50
Study 34360118 — intervention group
Group type: COMPARATOR
Intervention: Health education control group (n = 26)
Number of subjects: 50
Study 33084254 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine (titrated up to 45 mg/d for 8 weeks)
Number of subjects: 78
Study 33084254 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 78
Study 35620951 — intervention group
Group type: COMPARATOR
Intervention: Compound lidocaine cream with roller microneedles for 10 min, followed by rolling for 20 min (30 min test side)
Number of subjects: 90
Study 35620951 — intervention group
Group type: COMPARATOR
Intervention: Compound lidocaine cream with roller microneedles for 10 min, followed by rolling for 35 min (45 min test side)
Number of subjects: 90
Study 35620951 — intervention group
Group type: COMPARATOR
Intervention: Compound lidocaine cream with roller microneedles for 10 min, followed by rolling for 50 min (60 min test side)
Number of subjects: 90
Study 35620951 — intervention group
Group type: EXPERIMENTAL
Intervention: Control side: Compound lidocaine cream for 60 min
Number of subjects: 90
Study 35620951 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall effect of compound lidocaine cream with roller microneedles
Number of subjects: 90
Study 32675015 — intervention group
Group type: EXPERIMENTAL
Intervention: Dasatinib
Number of subjects: 179
Study 32675015 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 179
Study 35561718 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based rehabilitation intervention
Number of subjects: 0
Study 35561718 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32068167 — intervention group
Group type: COMPARATOR
Intervention: CGF
Number of subjects: 75
Study 32068167 — intervention group
Group type: COMPARATOR
Intervention: A-PRF
Number of subjects: 75
Study 32068167 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 75
Study 36147166 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum at 12 mmHg (group A)
Number of subjects: 2
Study 36147166 — intervention group
Group type: COMPARATOR
Intervention: Pneumoperitoneum at 8 mmHg (group B)
Number of subjects: 2
Study 34424217 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea mouthwash (13% infusion prepared with 13 g of green tea in 100 mL saline solution)
Number of subjects: 28
Study 34424217 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (placebo)
Number of subjects: 28
Study 33586283 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and compassion‐based intervention (MCBI)
Number of subjects: 90
Study 35102128 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic decision support tool (Microsoft HoloLens)
Number of subjects: 29
Study 35102128 — intervention group
Group type: COMPARATOR
Intervention: Control group (working from memory)
Number of subjects: 29
Study 33878589 — intervention group
Group type: EXPERIMENTAL
Intervention: SIDS group
Number of subjects: 115
Study 33878589 — intervention group
Group type: EXPERIMENTAL
Intervention: Infanticide group
Number of subjects: 115
Study 33878589 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 115
Study 35660790 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped Classroom (FC)
Number of subjects: 530
Study 35660790 — intervention group
Group type: COMPARATOR
Intervention: Traditional Didactic (TD)
Number of subjects: 530
Study 32989755 — intervention group
Group type: EXPERIMENTAL
Intervention: Edible stimuli
Number of subjects: 25
Study 32989755 — intervention group
Group type: EXPERIMENTAL
Intervention: Leisure stimuli
Number of subjects: 25
Study 32989755 — intervention group
Group type: COMPARATOR
Intervention: Assessment order
Number of subjects: 25
Study 34468110 — intervention group
Group type: EXPERIMENTAL
Intervention: Backward Walking Observational Training (BWOT)
Number of subjects: 24
Study 34468110 — intervention group
Group type: COMPARATOR
Intervention: Landscape Observational Training (LOT)
Number of subjects: 24
Study 32681453 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic capsule containing 1.6 × 10^9 CFU of bacteria
Number of subjects: 44
Study 32681453 — intervention group
Group type: COMPARATOR
Intervention: Inulin capsules (control group)
Number of subjects: 44
Study 34340595 — intervention group
Group type: EXPERIMENTAL
Intervention: Urate level increase (1 mg/dL)
Number of subjects: 397
Study 34340595 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic BP mediation
Number of subjects: 397
Study 33349136 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein first/Carbohydrate last (CL)
Number of subjects: 31
Study 33349136 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate first/Protein last (CF)
Number of subjects: 31
Study 33349136 — intervention group
Group type: COMPARATOR
Intervention: Composite meal (CM)
Number of subjects: 31
Study 32539740 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Connections (FC)
Number of subjects: 0
Study 32539740 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 0
Study 35531572 — intervention group
Group type: EXPERIMENTAL
Intervention: Whitegold Office 35% (WGO) bleaching agent
Number of subjects: 112
Study 35531572 — intervention group
Group type: EXPERIMENTAL
Intervention: Whiteness HP Auto Mixx 35% (WHP) bleaching agent
Number of subjects: 112
Study 35531572 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined bleaching agents (WGO and WHP)
Number of subjects: 112
Study 35531572 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillary lateral incisors
Number of subjects: 112
Study 35531572 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular incisors
Number of subjects: 112
Study 33370313 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat All implementation (after April 1, 2017)
Number of subjects: 300
Study 35727580 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline, 1 mg, twice daily for 12 weeks
Number of subjects: 300
Study 35727580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 34536584 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer Distress Coach app
Number of subjects: 400
Study 34536584 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 400
Study 34536584 — intervention group
Group type: EXPERIMENTAL
Intervention: coaching sessions in using the mobile app
Number of subjects: 400
Study 34536584 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT specific to HCT survivors
Number of subjects: 400
Study 34536584 — intervention group
Group type: EXPERIMENTAL
Intervention: Outcome measures of PTSD, depression, and anxiety
Number of subjects: 400
Study 36371180 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine treatment plus family-centered intensive health education
Number of subjects: 245
Study 36371180 — intervention group
Group type: COMPARATOR
Intervention: Routine community treatment
Number of subjects: 245
Study 33287881 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including one-hour educational outreach visits, an online course, and a clinical decision support system.
Number of subjects: 1217
Study 34340926 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold salt-water bath (23–26 °C) for 30 min every other day for 14 days
Number of subjects: 103
Study 34340926 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm salt-water bath (41 °C) for 30 min every other day for 14 days
Number of subjects: 103
Study 34340926 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 103
Study 32971277 — intervention group
Group type: EXPERIMENTAL
Intervention: PRACTICE-DM intervention (comprehensive HT-delivered intervention combining telemonitoring, self-management support, diet/activity support, medication management, and depression management)
Number of subjects: 200
Study 32971277 — intervention group
Group type: COMPARATOR
Intervention: Standard VHA Home Telehealth (HT) telemonitoring/care coordination
Number of subjects: 200
Study 32971277 — intervention group
Group type: EXPERIMENTAL
Intervention: PRACTICE-DM intervention
Number of subjects: 200
Study 33977674 — intervention group
Group type: EXPERIMENTAL
Intervention: 33°C training (HEAT)
Number of subjects: 17
Study 33977674 — intervention group
Group type: COMPARATOR
Intervention: 18°C training (TEMP)
Number of subjects: 17
Study 32539908 — intervention group
Group type: EXPERIMENTAL
Intervention: DBV712 250 µg epicutaneous patch
Number of subjects: 0
Study 36331895 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized Computerized Cognitive Training (CCT) for 6 weeks
Number of subjects: 30
Study 36331895 — intervention group
Group type: COMPARATOR
Intervention: Non-customized Computerized Cognitive Training (CCT) for 6 weeks
Number of subjects: 30
Study 33533713 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed reduction
Number of subjects: 47
Study 33533713 — intervention group
Group type: COMPARATOR
Intervention: No closed reduction
Number of subjects: 47
Study 35450527 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultramicronized PEA-LUT 770 mg plus olfactory training
Number of subjects: 185
Study 35450527 — intervention group
Group type: COMPARATOR
Intervention: Olfactory training with placebo
Number of subjects: 185
Study 33288333 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy rehabilitation program combined with music therapy
Number of subjects: 30
Study 33288333 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy rehabilitation program without music therapy
Number of subjects: 30
Study 35870074 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM)
Number of subjects: 37
Study 35870074 — intervention group
Group type: COMPARATOR
Intervention: First-generation flash glucose monitoring (FGM)
Number of subjects: 37
Study 32112436 — intervention group
Group type: EXPERIMENTAL
Intervention: digital cognitive behavioral therapy for insomnia (dCBT-I)
Number of subjects: 42
Study 35914746 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrosurgical bipolar device (LigaSureTM)
Number of subjects: 82
Study 35914746 — intervention group
Group type: COMPARATOR
Intervention: Conventional cut-and-ligate techniques (Control)
Number of subjects: 82
Study 34684393 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie-restricted Korean style Mediterranean diet (KMD)
Number of subjects: 92
Study 34684393 — intervention group
Group type: COMPARATOR
Intervention: Calorie-restricted conventional diet
Number of subjects: 92
Study 34991267 — intervention group
Group type: EXPERIMENTAL
Intervention: Organic food intervention for 40 days
Number of subjects: 149
Study 35344737 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (1.9 g docosahexaenoic acid and 0.22 g eicosapentaenoic acid)
Number of subjects: 228
Study 35344737 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Lacticaseibacillus rhamnosus HN001 and Bifidobacterium animalis ssp. lactis 420, 1010 colony-forming units each)
Number of subjects: 228
Study 35344737 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil + Probiotics
Number of subjects: 228
Study 35344737 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 228
Study 35344737 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal aMMP-8 level
Number of subjects: 228
Study 35344737 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary interventions (especially probiotics)
Number of subjects: 228
Study 32012082 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized walking program using an activity tracker
Number of subjects: 49
Study 32696178 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine supplementation (3 g/day for 8 weeks)
Number of subjects: 38
Study 32696178 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo for 8 weeks)
Number of subjects: 38
Study 33615370 — intervention group
Group type: EXPERIMENTAL
Intervention: iTBS targeting the left dlPFC
Number of subjects: 43
Study 33615370 — intervention group
Group type: EXPERIMENTAL
Intervention: iTBS targeting bilateral dmPFC
Number of subjects: 43
Study 33615370 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 43
Study 33988942 — intervention group
Group type: EXPERIMENTAL
Intervention: Interscalene block (ISB group)
Number of subjects: 48
Study 33988942 — intervention group
Group type: EXPERIMENTAL
Intervention: Superior trunk block (STB group)
Number of subjects: 48
Study 32475079 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepitel Film
Number of subjects: 39
Study 32475079 — intervention group
Group type: COMPARATOR
Intervention: Biafine cream
Number of subjects: 39
Study 34554368 — intervention group
Group type: EXPERIMENTAL
Intervention: CTO percutaneous coronary intervention (PCI)
Number of subjects: 174
Study 34554368 — intervention group
Group type: COMPARATOR
Intervention: No CTO-PCI
Number of subjects: 174
Study 34554368 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline RV FWLS
Number of subjects: 174
Study 34554368 — intervention group
Group type: EXPERIMENTAL
Intervention: RV GLS
Number of subjects: 174
Study 33622408 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratitude intervention program (1-month long)
Number of subjects: 0
Study 33622408 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 34380150 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper body resistance training (60% of 1 repetition maximum (1RM), 3×10 repetitions, 6 exercise stations, 2 times per week)
Number of subjects: 18
Study 34380150 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 18
Study 32994187 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 338
Study 32994187 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care
Number of subjects: 338
Study 33467135 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-rich oil
Number of subjects: 84
Study 33467135 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA-rich oil
Number of subjects: 84
Study 33467135 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 36208052 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 20
Study 36208052 — intervention group
Group type: COMPARATOR
Intervention: Lactose (placebo)
Number of subjects: 20
Study 32544011 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg CoQ10 capsules per day
Number of subjects: 43
Study 32544011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 34488817 — intervention group
Group type: EXPERIMENTAL
Intervention: VMAT
Number of subjects: 30
Study 34488817 — intervention group
Group type: COMPARATOR
Intervention: IMRT
Number of subjects: 30
Study 32955672 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Long Roux Limb LRYGB (VLRL‐LRYGB) (variable RL length, BPL 60 cm, and CC 100 cm)
Number of subjects: 444
Study 32955672 — intervention group
Group type: COMPARATOR
Intervention: Standard LRYGB (S‐LRYGB) (RL 150 cm, BPL 60 cm, and variable CC length)
Number of subjects: 444
Study 36184601 — intervention group
Group type: EXPERIMENTAL
Intervention: L-BAIBA 1500 mg (B1500)
Number of subjects: 12
Study 36184601 — intervention group
Group type: EXPERIMENTAL
Intervention: L-BAIBA 500 mg (B500)
Number of subjects: 12
Study 36184601 — intervention group
Group type: EXPERIMENTAL
Intervention: L-BAIBA 250 mg (B250)
Number of subjects: 12
Study 36184601 — intervention group
Group type: EXPERIMENTAL
Intervention: Valine 1500 mg (V1500)
Number of subjects: 12
Study 36184601 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study 33455201 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-fluorescent ELP fusion proteins co-transfected with a fluorescent ELP marker; specific dosage and duration not mentioned.
Number of subjects: 0
Study 33455201 — intervention group
Group type: COMPARATOR
Intervention: Single transfected treatments of ELP fusions; specific dosage and duration not mentioned.
Number of subjects: 0
Study 32641320 — intervention group
Group type: EXPERIMENTAL
Intervention: Bintrafusp alfa 1200 mg intravenously every 2 weeks
Number of subjects: 32
Study 35128361 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-day placement of balloon stent
Number of subjects: 91
Study 35128361 — intervention group
Group type: COMPARATOR
Intervention: Intrauterine device (IUD)
Number of subjects: 91
Study 33756279 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min of slumped sitting
Number of subjects: 15
Study 35843919 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal cannula on 15L of oxygen (Group II)
Number of subjects: 0
Study 35843919 — intervention group
Group type: COMPARATOR
Intervention: Nasal cannula on 6L of oxygen (Group I)
Number of subjects: 0
Study 35843919 — intervention group
Group type: EXPERIMENTAL
Intervention: Facemask on 15L of oxygen (Group IV)
Number of subjects: 0
Study 35843919 — intervention group
Group type: COMPARATOR
Intervention: Facemask on 6L of oxygen (Group III)
Number of subjects: 0
Study 33196146 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.0-mm homogenous treatment zone
Number of subjects: 23
Study 33196146 — intervention group
Group type: COMPARATOR
Intervention: 4.0-mm annular treatment zone
Number of subjects: 23
Study 36148315 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive postoperative antibiotics
Number of subjects: 0
Study 36148315 — intervention group
Group type: COMPARATOR
Intervention: Liberal postoperative antibiotics
Number of subjects: 0
Study 32561505 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Mobility training (n=33)
Number of subjects: 107
Study 32561505 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental/Leisure training (n=36)
Number of subjects: 107